European Biliary Atresia Registries: Summary of a Symposium

Abstract

Biliary atresia (BA) is a rare but potentially devastating disease. The European Biliary Atresia Registry (EBAR) was set up to improve data collection and to develop a pan-national and interdisciplinary strategy to improve clinical outcomes. From 2001 to 2005, 100 centers from 22 countries registered with EBAR via its website (www.biliary-atresia.com). In June 2006, the first meeting was held to evaluate results and launch further initiatives. During a 5-year period, 60 centers from 19 European countries and Israel sent completed registration forms for a total of 514 BA patients. Assuming the estimated incidence of BA in Europe is 1 : 18 000 live births, 35 % of the expected 1488 patients from all EBAR participating countries were captured, suggesting that reporting arrangements need improvement. At the meeting, the cumulative evaluation of 928 BA patients including patients from other registries with variable follow-up revealed an overall survival of 78 % (range from 41 % to 92 %), of whom 342 patients (37 %) have had liver transplants. Survival with native liver ranged from 14 % to 75 %. There was a marked variance in reported management and outcome by country (e.g., referral patterns, timing of surgery, centralization of surgery). In conclusion, EBAR represents the first attempt at an overall evaluation of the outcome of BA from a pan-European perspective. The natural history and outcome of biliary atresia is of considerable relevance to a European population. It is essential that there is further support for a pan-European registry with coordination of clinical standards, further participation of parent support groups, and implementation of online data entry and multidisciplinary clinical and basic research projects.

Key words

biliary atresia - registry - clinical research

References

• 1 Balistreri W F, Grand R, Hoofnagle J H. et al . Biliary atresia: current concepts and research directions. Summary of a symposium.  Hepatology. 1996;  23 1682-1692
• 2 Chardot C. Treatment for biliary atresia in 2003.  J Pediatr Gastroenterol Nutr. 2003;  37 407-408
• 3 Chardot C, Carton M, Spire Bendelac N, Le Pommelet C, Golmard J L, Auvert B. Epidemiology of biliary atresia in France: a national study 1986 - 96.  J Hepatology. 1999;  31 1006-1013
• 4 Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C. et al . Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996.  Hepatology. 1999;  30 606-611
• 5 Davenport M, De Ville de Goyet J, Stringer M D. et al . Seamless management of biliary atresia in England and Wales (1999 - 2002).  Lancet. 2004;  363 1354-1357
• 6 Davenport M, Ure B M, Petersen C. et al . Surgery for biliary atresia - is there a European consensus?.  Eur J Pediatr Surg. 2007;  17 180-183
• 7 Karrer F M, Lilly J R, Stewart B A. et al . Biliary atresia registry, 1976 to 1989.  J Pediatr Surg. 1990;  25 1076-1080
• 8 Kelly D. The United Kingdom restricts surgery for biliary atresia.  J Pediatr Gastroenterol Nutr. 1999;  29 529
• 9 Nio M, Ohi R, Miyano T. et al . Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry.  J Pediatr Surg. 2003;  38 997-1000
• 10 Petersen C. Biliary atresia: interdisciplinary initiatives focus on a rare disease.  Pediatr Surg Int. 2007;  23 521-527
• 11 Petersen C, Melter M, Leonhardt J. et al . Biliary atresia research is crossing national and interdisciplinary borderlines.  Acta Pediatrica . 2005;  94 526-527
• 12 Proceedings of the 6th International Sendai Symposium on Biliary Atresia. Japan, May 20 - 21, 1996.  Tohoku J Exp Med. 1997;  181 1-244
• 13 Schreiber R A, Kleinman R E. Biliary atresia.  J Pediatr Gastroenterol Nutr. 2002;  35 S11-S16
• 14 Serinet M O, Broue P, Jacquemin E, Lachaux A, Sarles J, Gottrand F, Gauthier F, Chardot C. Management of biliary atresia in France: results of a decentralised policy 1986 - 2002.  Hepatology. 2006;  44 75-84
• 15 Shneider B L, Brown M B, Haber B. et al . A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.  J Pediatr. 2006;  148 467-474
• 16 Sokol R J. New North American research network focuses on biliary atresia and neonatal liver disease.  J Pediatr Gastroenterol Nutr. 2003;  36 1
• 17 Sokol R J, Mack C, Narkewicz M R, Karrer F M. Pathogenesis and outcome of biliary atresia: current concepts.  J Pediatr Gastroenterol Nutr. 2003;  37 4-21
• 18 Sokol R J, Shepherd R W, Superina R. et al . Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.  Hepatology. 2007;  46 566-581